Original Research
Published on 03 Jun 2021
Regression of Castration-Resistant Prostate Cancer by a Novel Compound HG122
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2021.650919
- 5,415 views
- 5 citations



